← Back to the Areas of Interest
GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
View the full invitation
AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Programme and Faculty are preliminary and subject to change.
© 2019 cSLIDE CTI MEETING TECHNOLOGY. All rights reserved.